Company intelligence / Profile preview
Saisei Pharma
Moriguchi / Osaka / Kobe / Tokyo, Osaka Prefecture, Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
Saisei Pharma has developed patented generations of GcMAF-based products, including injectable and oral forms, with a focus on immune modulation for cancer, infectious diseases, autism, and other chronic conditions. Clinical trials have been conducted for oral MAF in COVID‑19 patients; however, most offerings are classified as food supplements rather than approved pharmaceuticals. The company emphasizes safety and individualized integrative medicine approaches.
- Therapeutic areas
- NeurologyPsychiatryInfectious DiseasesOncologyImmunology
- Modalities
- Protein (GcMAF, MAF series)Food supplement therapyDevice (ultrasonic sensitizers, electric field therapy such as TTF and ECCT)Gene therapy (liposomal gene therapy)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with Japanese universities including Tokushima UniversityPartnerships with domestic clinics in JapanInternational expansion partners in Serbia and Lithuania
Beyond the preview
Go deeper on Saisei Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Saisei Pharma.